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Aim To use the data on the AH1N1 2009 influenza epi-
demic in the Southern hemisphere countries to predict 
the course and size of the upcoming influenza epidemic in 
South-Eastern Europe (SEE) countries and other regions of 
the World with temperate climate.
Method We used a comparative epidemiological method 
to evaluate accessible electronic data on laboratory-con-
firmed deaths from AH1N1 2009 influenza in the seasons 
2009/2010 and 2010/2011. The studied SEE countries were 
Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Greece, 
Hungary, Kosovo, Macedonia, Montenegro, Romania, Ser-
bia, and Slovenia, while Southern hemisphere countries 
were Argentina, Australia, Chile, New Zealand, Paraguay, 
Uruguay, and South Africa.
Results In influenza season 2009/2010, Southern hemi-
sphere countries with temperate climate reported 1187 
laboratory-confirmed influenza AH1N1 2009 deaths (mor-
tality rate 0.84/100 000; 95% confidence interval [CI], 0.50-
1.24). SEE countries with similar climatic conditions report-
ed 659 deaths and similar mortality rates (0.86/100 000, 95% 
CI, 0.83-1.10). In the whole Europe without the Common-
wealth of Independent States countries (CIS, former Sovi-
et Union), there were 3213 deaths (0.60/100 000; 95% CI, 
0.65-0.93). In 2010/2011, Southern hemisphere countries 
reported 94 laboratory-confirmed deaths (mortality rate 
0.07/100 000; 95% CI, 0.02-0.28) or only 7.9% of the previ-
ous season. SEE countries by the end of the 11th epidemi-
ological week of 2010/2011 season reported 489 laborato-
ry-confirmed deaths, with a mortality rate of 0.64/100 000 
(95% CI, 0.26-0.96) or 74.2% of the previous season, which 
was significantly higher than in the Southern hemisphere 
countries  (χ2
1 = 609.1,  P < 0.001).  In  Europe  without  CIS 
countries, there were 1836 deaths, with a mortality rate of 
0.34/100 000 (χ2 = 153.3, P < 0.001 vs SEE countries).
Conclusion In the 2009/2010 season, SEE countries and 
Southern  hemisphere  countries  had  similar  influenza 
AH1N1 2009 mortality rates. In the 2010/2011 season, the 
forecast of 10% increase in total mortality in SEE countries 
and Europe compared with the 2009/2010 season was sig-
nificantly exceeded, while the expected impact of type-
specific vaccines against influenza AH1N1 2009 was not 
achieved. Consumption of epidemic potential has greater 
importance for the prognosis of the course and size of in-
fluenza epidemic than the degree of vaccine immunity.
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In order to plan anti-epidemic measures for infectious dis-
eases, including influenza, it is important to predict the 
course of each outbreak. This is mostly done by using his-
torical data of previous outbreaks (1). Modern means of 
communication, which allow simultaneous monitoring of 
influenza in different parts of the world, are used to collect 
data from the countries where an influenza epidemic has 
just finished to predict its course in the countries where it 
is yet to begin. With the outbreak of influenza AH1N1 2009, 
the World Health Organization (WHO) introduced labora-
tory monitoring of patients and deaths by detecting influ-
enza-specific RNA by real-time reverse transcriptase-poly-
merase chain reaction, available in all developed countries 
and many developing countries (2,3). The world now has 
much more reliable and comparable data based on a cor-
rect diagnosis of influenza virus types than the former prac-
tice of registration of patients with influenza-like illness 
and the number of deaths from influenza-like illness (2-6). 
Laboratory confirmation of deaths facilitates the compari-
son of epidemic course between countries and provides 
more accurate forecasts. We compared the available data 
from the 2010/2011 influenza season with the predictions 
for the same season, and we specifically compared SEE 
countries, which used different approaches to monitor the 
epidemic and perform the vaccination.
Method
We used electronically available mortality data on influ-
enza AH1N1 2009, collected and processed by govern-
mental institutions, international organizations, and other 
relevant sources that regularly register morbidity and mor-
tality (7-67). Mortality rate indicators (laboratory-confirmed 
deaths from AH1N1 2009) were calculated using the UN 
population estimate for each country (68). SEE countries 
include Bosnia and Herzegovina, Bulgaria, Croatia, Greece, 
Hungary, Kosovo, Macedonia, Montenegro, Romania, Ser-
bia, and Slovenia, that altogether have 76.4 million inhab-
itants (7-14,68). Europe includes 40 countries, without 13 
Commonwealth  of  Independent  States  (CIS)  countries, 
and has 534.1 million inhabitants. Northern hemisphere 
includes 69 countries without China and the countries of 
Central Asia, and has 1823.4 million inhabitants. Equatorial 
area includes 51 countries and has 1776.8 million inhab-
itants. North America includes United States of America 
(USA) and Canada and has 340 million inhabitants. The 
Western hemisphere (‘The New World’) includes 35 coun-
tries of the North, Central, and South America, and has 
904.0 million inhabitants. The Eastern hemisphere (‘The 
Old World’) includes 92 countries, with 2838.0 inhab-
itants. The Southern hemisphere includes Argentina, Aus-
tralia, Chile, New Zealand, Paraguay, Uruguay, and South 
Africa and has 141.7 million inhabitants.
We compared the countries and regions of the world dur-
ing the 2 most recent influenza seasons: 2009/2010 and 
2010/2011. As the epidemic broke out in Mexico at the 
end of April 2009, the data for the 2009/10 season are from 
May 2009 until the end of April 2010 (69). The 2010/11 in-
fluenza season started in May 2010 and ended with the 
11th epidemic week of 2011 (March 20, 2011).
Chi-square test was used to test the differences between 
data for the two seasons, using Statistica 7 software pack-
age (StatSoft, Tulsa, OK, USA).
ReSultS And diScuSSion
In Tables 1-4, the number of laboratory-confirmed influ-
enza deaths is summarized and compared between the 
countries of Europe, North America, Northern hemisphere, 
Western hemisphere, Eastern hemisphere, equatorial area, 
and the world. Out of 214 world countries, with 6724.3 mil-
lion inhabitants, 127 countries (3743.4 million inhabitants) 
adequately monitored and regularly reported on the num-
ber of laboratory-confirmed deaths.
The outbreak of influenza AH1N1 2009 in Mexico in April 
2009 was announced as the first catastrophic pandemic 
– the ‘young people killer’ influenza virus – of the third 
millennium. With the surrounding media frenzy, the in-
fluenza scare traveled quickly around the world (13-20), 
and frightened governments were forced to take action 
by activating the pandemic plans prepared after the pan-
demic avian influenza in 2005 (70-77). However, the first 
findings from Mexico, together with the course of the 
epidemic in the Southern hemisphere countries where 
local  winter  was  starting,  indicated  that  there  was  no 
exceptional, out-of-season outbreak of dangerous ‘killer 
virus.’ Instead, it was the usual epidemic of highly con-
tagious  influenza  virus  AH1N1  2009,  accompanied  by 
the usual low mortality and lethality as is the case for 
the  ordinary  seasonal  influenza  (15-20,48-50).  Indeed, 
the mortality in the 2009/2010 season was much lower 
than had been predicted by the WHO and the USA Cen-
ter for Disease Control (77-79). Based on the number of 
laboratory-confirmed deaths from influenza in Southern 
hemisphere countries, the expected mortality in North-
ern  hemisphere  countries,  where  winter  was  starting, 
was 0.84/100 000 population. It was estimated that the 117 Smoljanović et al: Predicting AH1N1 2009 influenza epidemic in Southeast Europe
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epidemic would be a single-wave, lasting 10-16 weeks, 
with the onset 2 months earlier than usual (80). It was 
expected that SEE countries would have lower mortality 
rates than the Southern hemisphere countries, due to the 
availability of the type-specific vaccine against influenza 
virus AH1N1 09 (80-82).
tAble 1. laboratory-confirmed deaths from influenza Ah1n1 09 per month in 2009/2010 season*
Season 2009/2010
Population 2009 2010
country  (million) V Vi Vii Viii iX X Xi Xii i ii iii iV total
Albania    3 . 2 6 6 0    0   0    1 2
Bosnia and 
Herzegovina
   4 . 0    1    8    2   8    0   0    1 9
Bulgaria    7 . 6    1    1    3   3 0    5   0    0   0    4 0
Croatia    4 . 5    1    9   1 4    5   0    3   0    3 2
Greece   1 1 . 2    1    2    0    9   5 8   3 6   34    6   3   1 4 9
Hungary   1 0 . 0    1    0    1    2    3   4 5   5 5   17    6   4   1 3 4
Kosovo       2.1    2   1 2    0   0    0   0    1 4
Macedonia       2.1    1   1 5    8   2    0   0    2 6
Montenegro    0 . 7    5    3   0    0   0     8
Romania   2 1 . 5    2   5 6   5 3   11    0   0   1 2 2
Serbia    7 . 5    1   1 6   3 8   2 6   2    0   1    8 4
Slovenia       2.0    2   1 1    6   0    0   0    1 9
Total South-Eastern 
Europe
  7 6 . 4    1    1    4    5   4 8   298   205   74   1 5   8   6 5 9
   0 . 2    0 . 2    0 . 6   0 . 7    7 . 3   4 5 . 2   3 1 . 5   11.2       2.3   1 . 2   1 0 0 %
Europe without CIS 
countries
  534.1   0   1   4 4    5 6    5 8   146   598 1179   637 217   228   49    3213
  0   0 . 0 3    1 . 4    1 . 7    1 . 8   4 . 5   1 8 . 6   3 6 . 7   1 9 . 8   6 . 7    7 . 1   1 . 5     1 0 0 %
Argentina   4 0 . 5   26   433    7   7 3   5 8   1 7    4   9   6 2 7
Australia   2 1 . 7   7   6 8   8 0   2 4    7    4    1   1 9 1
Chile   1 7   12   8 4   3 4    2    4   1 2    2    3   2   1 5 5
New Zealand    4 . 2   1 6   1 1   8    3 5
Paraguay    6 . 8   2 2   1 9   1 1   1    5 3
South Africa   4 8    2   2 5   3 2   3 2       2     9 3
Uruguay    3 . 5   1   2 4    5    3    3 3
Total Southern hemi-
sphere (7 countries)
  141.7   0   46   649   181   145   101   3 3    9    3   11    0   9    1187
  0   3 . 9   5 4 . 7   1 5 . 2     12.2    8 . 5      2.8    0 . 8    0 . 2   0 . 9    0   0 . 8     1 0 0 %
Equatorial area
(51 countries)†
1776.8   1   12   371 1011   922   675   400   711   451 328   420 146    5448
  0 . 2    6 . 8   1 8 . 6   1 6 . 9     12.4    7 . 3   1 3 . 1    8 . 3   6 . 0    7 . 7     2.7     1 0 0 %
Northern hemisphere 
(69 countries)†
1823.4 114 161   401   382 1543 1947 3031 3599 1696 514 1119 147 14 654
  0 . 8   1 . 1       2.5       2.6   1 0 . 5  1 3 . 3   2 0 . 7   2 4 . 6   1 1 . 6   3 . 5    7 . 6   1 . 0     1 0 0 %
The world (127 coun-
tries)†‡
3743.4 115 219 1421 1574 2610 2723 3464 4319 2150 853 1539 301 21 288
  0 . 5   1 . 0    6 . 7   7 . 4     12.3     12.8   1 6 . 3   2 0 . 3   1 0 . 1   4 . 0    7 . 2   1 . 4     1 0 0 %
Total Western hemi-
sphere (35 countries)†
  904.0 115 205 1182 1055 2134 2107 1572   954   506 432   393 173 10 828
  1 . 1   1 . 9   1 0 . 9    9 . 7   1 9 . 7   1 9 . 5   1 4 . 5    8 . 8    4 . 7   4 . 0    3 . 6  1 . 6     1 0 0 %
Total Eastern hemi-
sphere (92 countries)†
2838.0   0   14   239   519   476   616 1892 3365 1644 421 1146 128 10 460
  0   0 . 1       2.3    5 . 0    4 . 6   5 . 9   1 8 . 1     32.2   1 5 . 7   4 . 0   1 1 . 0   1 . 2     1 0 0 %
The world (214 coun-
tries)§
6724.3 115 219 1438 1590 2640 2741 3624 4902 2267 853 1542 302 22 233
  0 . 5   1 . 0    6 . 5    7 . 2   1 1 . 9     12.3   1 6 . 3   2 2 . 0   1 0 . 2   3 . 8    6 . 9   1 . 3     1 0 0 %
Total Northern 
America (2 countries)
  340.0   17 135   322   212 1385 1495 1031   489   174 113   8 9   29    5491
  0 . 3     2.5    5 . 9    3 . 9   2 5 . 2  2 7 . 2   1 8 . 8    8 . 9    3 . 2     2.1    1 . 6   0 . 5     1 0 0 %
*Shaded fields indicate enhanced seasonal influenza activity; ciS – commonwealth of independent States. Source: references 7-67.
†countries with total mortality rates in both seasons <0.10/100 000 were excluded from calculation.
‡Reliable data on influenza-related deaths were available for 127 countries.
§calculations for all 214 countries, regardless of the number of reported deaths.COVER PAGE 118 Croat Med J. 2011; 52: 115-25
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tAble 2. laboratory-confirmed deaths from influenza Ah1n1 09 per months in 2010/2011 season*
Season 2010/2011
Population 2010 2011
country (million) V Vi Vii Viii iX X Xi Xii i ii iii total
Albania    3 . 2   1    1
Bosnia and 
Herzegovina
   4 . 0   10    6   2   1 8
Bulgaria    7 . 6   1   30   7 0   27   128
Croatia    4 . 5   1   9   1 5   1   2 6
Greece   1 1 . 2   15   110   37   162
Hungary   1 0 . 0   4   3 1   36   7 1
Kosovo       2.1    2    2
Macedonia       2.1   5    4   8   1 7
Montenegro    0 . 7   5    1   1    7
Romania   2 1 . 5   3   3   1 2   14   3 2
Serbia    7 . 5   5   1 1   8   2 4
Slovenia       2.0   1    1
Total South-Eastern 
Europe
  7 6 . 4  0   0   0   0   0   0   0   5   88   262 134   489
  1 . 0   18.0   5 3 . 6 27.4   100%
Europe without CIS 
countries
  534.1  7   2   0   0   1   0   5   42 617   815 347 1836
  0.4   0 . 1   0 . 3     2.3   33.6   4 4 . 4   18.9   100%
Argentina   4 0 . 5   22   2 2
Australia   2 1 . 7   1   2   3   13   4   2 3
Chile   1 7   5   4   6   5   2 0
New Zealand    4 . 2   2   14   4   2 0
Paraguay    6 . 8    9    9
South Africa   4 8    0
Uruguay    3 . 5    0
Total Southern 
hemisphere
(7 countries)
  141.7  0   1   9   43   23   9   0   0   0    9   0   9 4
  1 . 1   9 . 6   45.7   24.5   9 . 6    9 . 6   100%
Equatorial area
(51 countries)†
1776.8 61   80 230 294 573 106 110 121   13   177   88 1853
  3.3   4 . 3   8 . 1   15.9   30.9   5 . 7   5.9   6 . 5   0 . 7    9 . 5   4 . 7   100%
Northern hemisphere 
(69 countries)†
1823.4 34   56   27   0   1   5   51 118 801 1040 700 2833
  1.2     2.0   1 . 0   0 . 2   1 . 8   4 . 2   28.3   3 6 . 7   24.7   100%
The world
(127 countries)†‡
3743.4 95 137 266 337 597 120 161 239 814 1226 800 4780
  2.0     2.9   5 . 5   7.1   12.5     2.5   3 . 4   5 . 0 17.0   2 5 . 6   16.7   100%
Total Western hemi-
sphere
(35 countries)†
  904.0 64   78   87   9   26   6   95   24   47   136 184   756
  8.5   10.3   11.5   1 . 2   3 . 4   0 . 8   12.6   3 . 2   6 . 2   1 8 . 0   24.3   100%
Total Eastern 
hemisphere
(92 countries)†
2838.0 31   59 179 328 571 114   66 215 767 1090 604 4024
  0.8   1 . 5   4 . 4   8 . 2   14.2     2.8   1 . 6   5 . 3   19.1   2 7 . 1   15.0   100%
The world
(214 countries)§
6724.3 95 137 267 315 597 119 168 235 863 1351 798 4945
  1.9     2.8   5 . 4   6 . 4   12.1     2.4   3 . 4   4 . 8 17.5   2 7 . 3   16.1   100%
Total Northern 
America
(2 countries)
  340.0  0   0   0   0   0   2   8   16   43   9 9   99   267
 0   0   0   0   0   0 . 7   3 . 0   6 . 0   16.1   3 7 . 1   37.1   100%
*Shaded fields indicate enhanced seasonal flu activity; ciS countries, commonwealth of independent States. Source: references 7-67.
†countries with total mortality rates in both seasons <0.10/100 000 were excluded from calculation.
‡Reliable data on influenza-related deaths were available for 127 countries.
§calculations for all 214 countries, regardless of the number of reported deaths.119 Smoljanović et al: Predicting AH1N1 2009 influenza epidemic in Southeast Europe
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After such experiences from 2009/2010 influenza season, 
a similar sequence of events was expected in 2010/2011 
season. By that time, the South hemisphere countries had 
had trivalent type-specific vaccines for AH1N1 2009 influ-
enza virus (83). The influenza season ended with a total 
of 96 registered laboratory-confirmed deaths (Tables 1-4). 
The highest mortality rate was in New Zealand (17), while 
Argentina, Australia, and Chile had a very low mortality 
rate and South Africa and Uruguay had no laboratory-
confirmed deaths (15-20). The data on vaccination cover-
age were not available for all countries, but were reliable 
for New Zealand and Argentina, where about a quarter of 
the total population was vaccinated: 1.1 million in New 
Zealand and 10 million in Argentina (83-85). Despite the 
similar vaccination coverage, the mortality in Argentina 
(0.05/100 000) was significantly lower than in New Zea-
land (0.48/100 000). Also, the mortality in New Zealand 
did not differ from that in 2009/2010, despite vaccination 
(0.83/100 000; χ2
1 = 3.56, P > 0.10) (15,17).
In the 2010/2011 season, Southern hemisphere countries 
recorded  only  7.9%  (95%  confidence  interval  [CI],  3.74-
33.03) of laboratory-confirmed influenza deaths, less than 
in the previous season; χ2
1 = 930.9, P < 0.001).
As the influenza season in the Southern hemisphere pre-
cedes the one in the Northern hemisphere, it was expect-
ed that Northern hemisphere countries would also have 
a similar lower mortality rate. By the end of the 11th epi-
demic week (March 20, 2011, the end of influenza season), 
in  North  American  countries  267  laboratory-confirmed 
deaths were recorded, with a mortality rate of 0.08/100 000 
or only 4.7% of the 2009/10 season. According to the Cen-
ters for Disease Control weekly reports on the total num-
ber of laboratory-confirmed deaths from different types of 
influenza viruses, deaths from influenza virus AH1N1 2009 
made up at most a third of the cumulative number of all 
types of influenza viruses in the USA (48). Mexico did not 
report any deaths caused by influenza AH1N1 2009 virus 
tAble 3. comparison of Ah1n1 09 mortality during influenza seasons in South-eastern europe and in southern hemisphere, where 
the Ah1n1 09 flu originated in 2009*
Season 
2009/2010
Season 
2010/2011
 
both seasons
Ratio 2010/2011 
vs 2009/2010
country
Population 
(million)
number 
of deaths
mortality 
per 100 000
number 
of deaths
mortality 
per 100 000
number 
of deaths
mortality 
per 100 000
 
ratio
 
%
Albania   3 . 2   1 2 0.38   1 † 0.03   1 3 0.41   1 / 1 2   8 . 3
Bosnia and 
Herzegovina
  4 . 0   1 9 0.48   18 0.45   3 7 0.93   18/19   94.7
Bulgaria   7 . 6   4 0 0.53 128† 1.68   168 2.21 128/40 320.0
Croatia   4 . 5   3 2 0.71   26 0.58   5 8 1.29   26/32   81.3
Greece   11.2   149 1.33 162 1.45   311 2.78 162/149 108.7
Hungary   10.0   134 1.34   71† 0.71   205 2.05   71/134   53.0
Kosovo     2.1   1 4 0.67   2 † 0.09   1 6 0.76   2 / 1 4   14.3
Macedonia     2.1   2 6 1.24   17 0.81   4 3 2.05   17/26   65.4
Montenegro   0 . 7    8 1.14   7 1.00   1 5 2.14   7 / 8 87.5
Romania   21.5   122† 0.57   32† 0.15   154 0.72   32/122   26.2
Serbia   7 . 5   8 4 † 1.12   24† 0.32   108 1.44   24/84   28.6
Slovenia     2.0   1 9 † 0.95   1 † 0.05   2 0 1.00   1 / 1 9   5 . 3
Total South-Eastern 
Europe
  76.4   659 0.86
(0.65-1.1)
489 0.64
(0.26-0.96)†
1148 1.50
(1.01-1.96)‡
489/659   74.2‡
Argentina   40.5   627 1.55   22† 0.05   649 1.60   22/627   3 . 5
Australia   21.7   191 0.88   23† 0.11   214 0.99   23/191   12.0
Chile   17   155 0.91   20† 0.12   175 1.03   20/155   12.9
New Zealand   4 . 2   3 5 0.83   20 0.48   5 5 1.31   20/35   57.1
Paraguay   6 . 8   5 3 0.78   9 † 0.13   6 2 0.91   9 / 5 3   17.0
South Africa   4 8   9 3 0.19   0 0   9 3 0.19     0/93   0
Uruguay   3 . 5   3 3 0.94   0 0   3 3 0.94   0 / 3 3   0
Total southern 
hemisphere
141.7 1187 0.84
(0.5-1.2)
  94 0.07
(-0.02-0.28)†
1281 0.91
(0.6-1.4)
  94/1187   7 . 9
*numbers in brackets are 95% confidence intervals.
†P < 0.001 vs previous year (χ2 test).
‡P < 0.001 vs Southern hemisphere (χ2 test).COVER PAGE 120 Croat Med J. 2011; 52: 115-25
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and reported a low morbidity, just confirming the pres-
ence of influenza AH1N1 2009 virus in circulation. Canada 
reported 13 laboratory-confirmed deaths (48-50). The total 
number of laboratory-confirmed deaths in the Northern 
hemisphere was 2823 or only 19.3% of the previous sea-
son. For all the world countries, the laboratory-confirmed 
influenza mortality reached 22.2% of that in the previous 
season.
In  Europe  without  the  CIS,  all  countries  recorded  low-
er  laboratory-confirmed  mortality  in  2010/2011  than  in 
2009/2010 (0.34 vs 0.60). The percentage of laboratory-
confirmed  deaths  (n = 1836)  was  57.1%  of  that  for  the 
2009/10 season (n = 3213). The lower mortality rate in Eu-
rope than in Southern hemisphere countries in the sea-
son 2009/2010 (0.60 vs 0.84, χ2
1 = 95.5, P < 0.001) indirectly 
points to a smaller consumption of epidemic potential in 
that season in Europe.
In 2009/10 influenza season, SEE countries had an average 
mortality rate similar to Southern hemisphere countries 
(Table 1). In 2010/2011 season, the percentage of labora-
tory-confirmed deaths was 74.2% of that in the previous 
season.  In  Croatia,  the  mortality  in  the  2010/2011  sea-
son until March 14, 2011 was similar to that in 2009/2010 
(0.71/100 000 vs 0.58/100 000; χ2
1 = 0.43, P = 0.20). This was 
despite  the  fact  that  in  2009/2010  season  fewer  than 
20 000 persons (0.4% of the population) were vaccinated, 
due to delayed administration of influenza vaccine H1N1A 
09, compared with more than 550 000 (more than 12% of 
population) in the second season (Figure 1).
In 2010/2011, an even higher mortality rate than in Croatia 
was recorded in Greece, which also had a higher mortality 
in the 2009/2010 season (Tables 1 and 2). In 2010/2011, 
only 3.5% of Greek population was vaccinated (9). In con-
trast, the UK, in which more than 70% of the risk-group 
population was vaccinated, also had a high laboratory-
confirmed mortality in 2010/2011 (22).
Poland is the only European country that refused the pur-
chase  of  type-specific  vaccine  against  influenza  AH1N1 
2009 in the 2009/2010 season. If the last available vaccina-
tion coverage for Poland from 2008 is used to estimate the 
current vaccination coverage (10% of the population older 
than 65 years), it is clear that the type-specific vaccine can-
not be the reason for significantly lower overall laborato-
ry-confirmed influenza mortality in Poland (0.78/100 000) 
tAble 4. total mortality rates of laboratory-confirmed deaths from influenza Ah1n1 09 for world’s regions in both seasons
2009/2010 season 2010/2011 season both seasons
2010/2011 vs 
2009/2010 season
country
Population 
(million)
no. 
deaths
mortality 
per 100 000
no. 
deaths
mortality 
per 100 000
no. 
deaths
mortality 
per 100 000 number %
Northern America
(2 countries)
  340.0    5491 1.62   267 0.08†    5758 1.69   267/5491   4.9
South-Eastern Europe
(12 countries)
  7 6 . 4      659 0.86   489 0.64†    1148 1.50   489/659 74.2
Western hemisphere (35 
countries)*
  904.0 10 828 1.20   756 0.08† 11 584 1.28   756/10 828   7.0
Northern hemisphere (69 
countries)*
1823.4 14 654 0.80 2823 0.15 17 477 0.96 2823/14 654 19.3
Europe without CIS countries
(40 countries)
  534.1    3213 0.60 1836 0.34    5049 0.94 1836/3213 57.1
Southern hemisphere
(7 countries)*
  141.7    1187 0.84   9 4 0.07    1281 0.91   9 4 / 1 1 8 7   7.9
The world
(127 countries)*‡
3743.4 21 289 0.57 4780 0.13† 26 069 0.70 4780/21 289 22.5
Eastern hemisphere
(92 countries)*
2838.0 10 460 0.37 4024 0.14† 14  484 0.51 4024/10 460 38.4
Equatorial area
(51 countries)*
1776.8    5448 0.31 1853 0.10†    7301 0.41 1853/5448 34.0
The world
(214 countries)§
6724.3 22 233 0.33 4945 0.07 27 078 0.40 4945/22 233 22.2
*countries with total mortality rates <0.10/100 000 for both seasons were excluded from calculation. Sources: references 7-67.
†P < 0.001 vs previous season.
‡Reliable data on influenza-related deaths were available for 127 countries.
§calculations for all 214 countries, regardless of the number of reported deaths.121 Smoljanović et al: Predicting AH1N1 2009 influenza epidemic in Southeast Europe
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than in the UK (1.55/100 000) in both seasons (χ2
1 = 112.2, 
P < 0.001) (38,81).
As the current data on vaccine coverage are not avail-
able for 22 EU countries, the data for the seasonal influ-
enza in 2008 could be used (Figure 2). Since our practice 
in the field shows that the desired vaccination coverage 
is not achieved rapidly and that the habit of vaccination 
is not rapidly lost, similar vaccination coverage could be 
expected for the 2010/11 season. In 2009/2010 season, 
when  type-specific  vaccines  against  influenza  AH1N1 
2009 were not timely available in EU countries, laborato-
ry-confirmed deaths mortality rate in the >65 age group 
linearly increased as the vaccination coverage decreased 
(Figure 2). In 2010/2011 season, when the vaccines were 
available, greater vaccine coverage was not followed by a 
lower mortality rate (13,14,21-39,81).
The comparison of laboratory-confirmed AH1N1 2009 mor-
tality rates among countries, even without sero-epidemio-
logical field investigation, and detailed analysis by time, age, 
disability, geographic distribution, and with no valid data 
on the volume of applied non-pharmaceutical and phar-
maceutical measures (vaccines and antivirals for preven-
tive purposes) demonstrated that anti-epidemic protection 
measures by type-specific vaccines against AH1N1 2009 
influenza virus in 2010/11 in SEE, Europe, and all Northern 
hemisphere countries did not result in a lower expected 
mortality rate than in Southern hemisphere countries.
Countries of the Western hemisphere, which had a higher 
rate of laboratory-confirmed influenza AH1N1 2009 deaths, 
ie, greater active infectious immunity by natural contact 
with influenza virus during the 2009/10 season, and thus 
greater estimated consumption of epidemic potential, had 
a  significantly  smaller  number  of  laboratory-confirmed 
deaths in the 2010/11 season (Figure 3) than in 2009/2010, 
compared with the Eastern hemisphere (Table 2, Figure 3).
With the growing evidence on the questionable efficacy of 
influenza vaccines (86-89) and despite the lack of reliable 
sero-epidemiological  studies,  the  pattern  of  laboratory-
confirmed AH1N1 2009 mortality indicated that Western 
hemisphere  countries  achieved  a  higher  degree  of  ac-
quired active, infectious immunity than other world regions 
Figure 1.
influenza Ah1n1 2009 in croatia, number of specimens processed (open 
columns), number of detected influenza virus Ah1n1 2009 cases (gray 
columns) and number of laboratory confirmed deaths (triangles and 
framed number). Sources: croatian Public health institute (8) and Who 
Flunet, http://apps.who.int/globalatlas/dataQuery/default.asp.
Figure 3.
cumulative  (closed  rhombs)  and  quarterly  (open  squares)  mortality 
rates of laboratory confirmed deaths of influenza Ah1n1 2009 in differ-
ent global areas. numbers present the mortality rates for 2009/10 sea-
son (single underlined) and 2010/11 (double underlined). Sources: ref-
erences 7-67.
Figure 2.
Mortality rates of laboratory confirmed deaths of influenza Ah1n1 2009 
in 2009/10 season (closed rhombs and full line) and 2010/11 season 
(open squares and broken line) in relation to estimated vaccination cov-
erage in eu countries. Asterisks and numbers indicate the data for the 
uK, the country with high vaccination coverage, and Poland (low vac-
cination coverage), where Poland had significantly lower mortality than 
the uK in both seasons (P < 0.001) despite lower vaccination coverage. 
Sources: references 2,3,5-14,21-39,81.COVER PAGE 122 Croat Med J. 2011; 52: 115-25
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(Table 4, Figure 3). Also, the expected epidemiological ef-
fect of vaccine immunity was not achieved. This suggests 
that infectious immunity has greater epidemiological sig-
nificance than vaccine immunity. This is supported by the 
fact that people older than 55 years had lower morbidity in 
all parts of the world (7-67), indicating that they had been 
actively immunized with the infectious virus AH1N1 2009 
during their life. No less important is the fact that infec-
tious immunity provides a high degree of crossed immu-
nity to other influenza viruses (90), while vaccine immunity 
lasts no longer than a year, is highly type-specific, and the 
possibility of crossed immunity is minimal (88,89,91). We 
believe that these findings clearly demonstrate that, from 
an epidemiological point of view, the vaccination for influ-
enza during its outbreak should be reserved for health-risk 
groups. Healthy people need not get vaccinated, especial-
ly not in mass vaccination.
Data obtained by type-specific diagnostic tests in the two 
AH1N1  2009  influenza  seasons  brought  into  the  ques-
tion the previous estimates of 250 000 to 500 000 annual 
deaths from influenza (77-79). It was estimated that in the 
2009/2010  season,  the  overall  laboratory-confirmed  in-
fluenza mortality rate in 214 countries with 6.742 million 
population would be 0.57/100 000, ie 38 500 deaths (Table 
4). Taking into consideration the Centers for Disease Con-
trol estimate that only a third of influenza deaths are lab-
oratory-confirmed (48), this number could reach 115 500 
deaths. So far in the 2010/2011 influenza season, which is 
at its very end, the final estimated death toll is 25 000.
In addition to AH1N1 2009 influenza virus, other influen-
za viruses A and B were in circulation in different parts of 
the world (92). In the countries that used laboratory con-
firmation of influenza deaths, the total mortality of other 
influenza deaths did not exceed that of the AH1N1 2009 
influenza (13), suggesting that the total annual number 
of deaths from all types influenza viruses did not exceed 
50 000 in 2010/2011. From this perspective, the estimates 
of 250 000 to 500 000 annual deaths should be replaced by 
50 000 to 150 000 annual deaths.
By studying the natural experiment of the influenza AH1N1 
2009  epidemics  during  two  seasons  and  by  using  the 
number of laboratory-confirmed deaths, we can provide 
a more accurate and reliable prognosis for the upcoming 
2011/2012 season. Because of the attenuation of the epi-
demic potential, countries of West hemisphere will not 
have epidemic occurrence of influenza a H1N1 2009 
above the usual average of any seasonal influenza. 
The countries of Eastern hemisphere will have a low epi-
demic occurrence only in the countries and areas where 
the total mortality rate was below 1.25/100 000 during the 
previous two seasons. The equatorial area countries will 
have the usual epidemic activity for another season but of 
lower intensity than in the previous season (Table 4, Figure 
3). Influenza virus AH1N1 2009 will continue its circulation 
around the world as the common seasonal influenza virus 
did at the beginning of April 2009.
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